Position Statements
Position Statements
Our position statements express the opinions of GOC on a variety of topics or issues related to gynecologic oncology. They are all based on evidence, research, and expert consensus, and they aim to provide guidance, recommendations, and gynecologic oncology standards.
Guidelines
Guidelines
The GOC Guidelines are statements that provide recommendations for the diagnosis, treatment, or prevention of gynecologic cancers based on the best available evidence and expert consensus.
Other Publications
Other Publications
Other publications include opinion statements, white papers, responses and the like.
CA 125 Monitoring in the Management of Recurrent Ovarian Cancer
Results of a multi-institutional European trial comparing early treatment of relapsed ovarian cancer based on CA125 only versus delayed treatment based on conventional clinical indicators after completion of first line chemotherapy, was presented at the American Society of Clinical Oncology meeting (ASCO) on May 31st.
Read moreCA 125 Monitoring in the Management of Recurrent Ovarian Cancer
Results of a multi-institutional European trial comparing early treatment of relapsed ovarian cancer based on CA125 only versus delayed treatment based on conventional clinical indicators after completion of first line chemotherapy, was presented at the American Society of Clinical Oncology meeting (ASCO) on May 31st.
Read moreCA 125 Monitoring in the Management of Recurrent Ovarian Cancer
Results of a multi-institutional European trial comparing early treatment of relapsed ovarian cancer based on CA125 only versus delayed treatment based on conventional clinical indicators after completion of first line chemotherapy, was presented at the American Society of Clinical Oncology meeting (ASCO) on May 31st.
Read more
English 
French